featured
Efficacy and Safety of Baricitinib in the Management of Adults With COVID-19 on Invasive Mechanical Ventilation or ECMO
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
Lancet Respir Med 2022 Feb 03;[EPub Ahead of Print], EW Ely, AV Ramanan, CE Kartman, S de Bono, R Liao, MLB Piruzeli, JD Goldman, JFK Saraiva, S Chakladar, VC MarconiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.